Position in VCEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$17,723,258
+$4,821,641 QoQ
Shares Held
398,365
-0.7% QoQ
Ownership
0.778%
of shares outstanding
% of Portfolio
0.96%
of 13F equity value
Holder Rank
#35
of 315 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026OSTERWEIS CAPITAL MANAGEMENT INC holds $28,588,525 across 6 Biotechnology names. VCEL ranks #1 (62.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VCEL |
Vericel Corp
This page
|
398,365 | $17,723,258 | |
| 2 | COGT |
Cogent Biosciences, Inc.
|
172,085 | $6,659,689 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
50,315 | $4,101,175 | |
| 4 | SMMT |
Summit Therapeutics Inc.
|
5,000 | $72,850 | |
| 5 | SPRY |
ARS Pharmaceuticals, Inc.
|
2,637 | $21,122 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
21 | $10,431 |
All Filings in VCEL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,723,258 | 398,365 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,901,617 | 401,045 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,630,329 | 322,975 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $9,694,490 | 308,055 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,713,101 | 228,275 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||